We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+8.48%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.8B
AUM Growth
+$629M
Cap. Flow
-$312M
Cap. Flow %
-2.1%
Top 10 Hldgs %
24.14%
Holding
917
New
50
Increased
256
Reduced
457
Closed
57

Top Buys

Rank Stock Value
1
VERU icon
Veru
VERU
+$53M
2
MELI icon
Mercado Libre
MELI
+$43.2M
3
DAR icon
Darling Ingredients
DAR
+$41.7M
4
JNJ icon
Johnson & Johnson
JNJ
+$33.7M
5
MET icon
MetLife
MET
+$31.1M

Top Sells

Rank Stock Value
1
PEP icon
PepsiCo
PEP
+$46.1M
2
NKE icon
Nike
NKE
+$36.6M
3
ITW icon
Illinois Tool Works
ITW
+$35.8M
4
AAPL icon
Apple
AAPL
+$31.9M
5
GILD icon
Gilead Sciences
GILD
+$29.8M

Sector Composition

Rank Sector Weight
1 Healthcare 33.32%
2 Technology 22.84%
3 Financials 10.04%
4 Consumer Discretionary 7.69%
5 Industrials 7.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HOG icon
326
Harley-Davidson
HOG
$2.61B
$7.04M 0.05%
+169,187
New +$7.2M
AZPN
327
DELISTED
Aspen Technology Inc
AZPN
$6.84M 0.05%
33,294
+14,264
+75% +$3.31M
IDXX icon
328
Idexx Laboratories
IDXX
$44.9B
$6.83M 0.05%
16,741
+984
+6% +$382K
AIG icon
329
American International
AIG
$42.5B
$6.81M 0.05%
107,647
-20,491
-16% -$1.19M
IMCR icon
330
Immunocore
IMCR
$1.7B
$6.8M 0.05%
119,075
-247
-0.2% -$13.9K
SLB icon
331
SLB Ltd
SLB
$72.7B
$6.72M 0.05%
125,737
-33,763
-21% -$1.68M
XIFR
332
XPLR Infrastructure LP
XIFR
$1.04B
$6.72M 0.05%
95,828
-178,647
-65% -$13.4M
BKNG icon
333
Booking.com
BKNG
$156B
$6.61M 0.04%
82,025
-74,650
-48% -$5.67M
WELL icon
334
Welltower
WELL
$173B
$6.61M 0.04%
100,800
+61,070
+154% +$3.93M
DICE
335
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
$6.55M 0.04%
+210,000
New +$6.85M
JKHY icon
336
Jack Henry & Associates
JKHY
$11.4B
$6.53M 0.04%
37,199
-10,680
-22% -$1.97M
INDA icon
337
iShares MSCI India ETF
INDA
$6.81B
$6.48M 0.04%
155,160
+300
+0.2% +$12.7K
DXCM icon
338
DexCom
DXCM
$29B
$6.41M 0.04%
56,566
-69,503
-55% -$7.63M
STRO icon
339
Sutro Biopharma
STRO
$386M
$6.38M 0.04%
78,918
-100,966
-56% -$7.02M
PH icon
340
Parker-Hannifin
PH
$120B
$6.35M 0.04%
21,813
-1,864
-8% -$534K
KMB icon
341
Kimberly-Clark
KMB
$37.6B
$6.25M 0.04%
46,055
-4,151
-8% -$527K
RAPT
342
DELISTED
RAPT Therapeutics
RAPT
$6.2M 0.04%
39,158
– –
BNY
343
Bank of New York Mellon
BNY
$103B
$6.15M 0.04%
135,153
+4,480
+3% +$192K
PRU icon
344
Prudential Financial
PRU
$42.6B
$6.07M 0.04%
61,044
-8,447
-12% -$855K
TSCO icon
345
Tractor Supply
TSCO
$16.3B
$6.06M 0.04%
134,760
+11,820
+10% +$502K
MPC icon
346
Marathon Petroleum
MPC
$90.1B
$6.05M 0.04%
52,007
+14,922
+40% +$1.7M
AAWW
347
DELISTED
Atlas Air Worldwide Holdings, Inc.
AAWW
$6.05M 0.04%
59,981
-32,952
-35% -$3.3M
CBRE icon
348
CBRE Group
CBRE
$43.3B
$5.97M 0.04%
77,603
-27,325
-26% -$2.02M
FHN icon
349
First Horizon
FHN
$12.2B
$5.94M 0.04%
242,593
+9,798
+4% +$237K
FORG
350
DELISTED
ForgeRock, Inc.
FORG
$5.86M 0.04%
+257,532
New +$5.61M
12 13
14
15 16

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q4 2022 Portfolio in Review

As of Q4 2022, Candriam SCA held 917 positions worth $14.8B, up 4.4% from $14.2B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Candriam SCA's Q4 2022 filing shows 50 new, 256 increased, 457 reduced and 57 closed positions. Its largest new stake was Sarepta Therapeutics: 95,144 shares worth $12.3M. The largest sale was PepsiCo, an estimated $46.1M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 32% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q4 2022 buy was Sarepta Therapeutics: 95,144 shares worth $12.3M.
  • Candriam SCA added most to Veru in Q4 2022, an estimated $53M increase.
  • Candriam SCA's biggest Q4 2022 reduction was PepsiCo, cutting an estimated $46.1M.
  • Candriam SCA fully exited Global Blood Therapeutics, Inc. in Q4 2022, selling an estimated $24.6M.
  • Candriam SCA's ten largest holdings make up 24% of its $14.8B portfolio in Q4 2022.
  • Candriam SCA opened 50 new positions and closed 57 in Q4 2022.
  • Candriam SCA's portfolio value rose 4.4% quarter-over-quarter to $14.8B.

Based on Candriam SCA's 13F filing for Q4 2022, filed 13 Feb 2023.